drugset / Trial / NCT04278846

Efficacy of Liposomal Bupivacaine for Prolonged Postoperative Analgesia in Patient Undergoing Breast Reconstruction With Tissue Expander

NCT04278846 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

Patients undergoing breast reconstruction with tissue expanders will be treated with a local anesthetic during their procedure and monitor their post-operative pain level and amount of oral pain medication taken. This information will be used to determine if liposomal bupivacaine provides better and longer pain control vs. bupivacaine HCl.

Timeline

Start
2014-08-22
Primary completion
2017-12-31
Completion
2019-05-15

Outcome

Missed primary endpoint

registry analysis (superiority test); DepoFoam Bupivacaine vs Bupivacaine HCl; p = .87; Kruskal-Wallis NCT04278846 ↗

registry analysis (superiority test); DepoFoam Bupivacaine vs Bupivacaine HCl; p = .57; Kruskal-Wallis NCT04278846 ↗

registry analysis (superiority test); DepoFoam Bupivacaine vs Bupivacaine HCl; p = .99; Kruskal-Wallis NCT04278846 ↗

registry analysis (superiority test); DepoFoam Bupivacaine vs Bupivacaine HCl; p = .12; Kruskal-Wallis NCT04278846 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine hydrochloride (HCl) Unknown — Other
Subject Depofoam bupivacaine Unknown — Other

Indications